How to Sell a Veterinary Specialty Hospital (2026): 10x-18x EBITDA & Buyers
Quick Answer
Christoph Totter · Managing Partner, CT Acquisitions
M&A advisory across 500+ active capital partners · Vet specialty / 24-hour ER M&A: 10x-18x EBITDA tier · Updated June 8, 2026
A US veterinary specialty hospital (24-hour ER + multi-specialty referral) in 2026 typically sells for roughly 10x to 18x EBITDA, among the highest multiples in healthcare-services M&A. Vet specialty is structurally premium because of high-acuity case mix, cash-pay revenue model (~70%+ cash, no insurance complexity), aging-pet-population demand, and durable customer relationships. By profile: a single-site mixed practice with limited ER ($1-3M EBITDA) goes 8x-11x; a dedicated single-site 24-hour ER ($2-5M EBITDA) goes 10x-13x; a single-site multi-specialty referral hospital ($3-8M EBITDA, surgery + internal medicine + emergency) goes 12x-15x; a mid-size multi-site specialty platform ($8-25M EBITDA) goes 13x-16x; a premium scale platform ($25M+ EBITDA, multi-state, comprehensive specialty + ER + boarding) reaches 15x-18x+. Active buyers include Mars Petcare Veterinary Health (Mars Inc. subsidiary, includes VCA Animal Hospitals ~1,000+ hospitals, BluePearl ~115+ specialty hospitals, Banfield Pet Hospital ~1,000+ clinics in PetSmart stores), Thrive Pet Healthcare (TSG Consumer Partners, ~400+ veterinary hospitals), National Veterinary Associates / NVA (KKR + Berkshire Partners, ~1,400+ hospitals globally), MedVet (PE-backed, multi-state specialty + ER), Veterinary Emergency Group / VEG (PE-backed, ER-only multi-site), Ethos Veterinary Health (Ethos Veterinary Hospitals + Compassion-First Pet Hospitals, multi-specialty), AmeriVet Veterinary Partners (PE-backed), Encore Vet Group (PE-backed), plus PE sponsors (KKR + Berkshire Partners, TSG Consumer Partners, Carlyle Group, Apax Partners, JAB Holding Company). The biggest multiple drivers are specialty mix (surgery, internal medicine, oncology, neurology, cardiology, emergency, dentistry, ophthalmology, dermatology), 24-hour ER coverage, cash-pay revenue model, modern operating system (Cornerstone, ezyVet, Provet, IDEXX Neo), referring DVM (rDVM) network strength, and board-certified specialist bench depth. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing.
If you own a US veterinary specialty hospital in 2026, the M&A market is structurally premium, multiples among the highest in any healthcare-services category (10x-18x EBITDA). Mars Petcare Veterinary Health dominates with VCA Animal Hospitals (~1,000+), BluePearl (~115+ specialty), and Banfield (~1,000+ PetSmart clinics). Thrive Pet Healthcare (TSG Consumer Partners), NVA (KKR + Berkshire Partners), MedVet, VEG, and Ethos Veterinary Health compete. PE sponsors continue aggressive consolidation.
What the asset is worth depends on three things: (1) specialty mix and 24-hour ER coverage (multi-specialty + ER is premium), (2) cash-pay revenue model (~70%+ cash, no insurance complexity), and (3) referring DVM network strength plus board-certified specialist bench. This guide covers real multiples by profile, the named buyers transacting, and the operator-level diligence buyers will run.
What this guide covers
- Vet specialty hospital multiples 2026: 8x-11x for mixed practice with limited ER, 10x-13x for dedicated 24-hour ER, 12x-15x for single-site multi-specialty, 13x-16x for mid-size multi-site, 15x-18x+ for premium scale. Among the highest multiples in healthcare-services M&A.
- Active buyers: Mars Petcare Veterinary Health (Mars Inc. subsidiary, VCA Animal Hospitals ~1,000+ + BluePearl ~115+ specialty + Banfield ~1,000+ PetSmart clinics), Thrive Pet Healthcare (TSG Consumer Partners, ~400+ hospitals), National Veterinary Associates / NVA (KKR + Berkshire Partners, ~1,400+ hospitals globally), MedVet (PE), Veterinary Emergency Group / VEG (PE, ER-only), Ethos Veterinary Health, AmeriVet Veterinary Partners (PE), Encore Vet Group (PE).
- PE sponsor activity: KKR + Berkshire Partners (NVA), TSG Consumer Partners (Thrive), Carlyle Group, Apax Partners, JAB Holding Company.
- Multiple drivers: specialty mix (surgery, internal medicine, oncology, neurology, cardiology, ER, dentistry, ophthalmology, dermatology), 24-hour ER coverage, cash-pay model (~70%+), modern operating system (Cornerstone, ezyVet, Provet, IDEXX Neo), referring DVM (rDVM) network strength, board-certified specialist bench depth.
- Things that compress: weak specialty mix, no 24-hour ER, weak rDVM relationships, owner-veterinarian dependence, weak operating system, single-state operations.
- No fee to you on buy-side introductions; sell-side mandates are paid on success at closing.
Named M&A transactions (2021-2025)
CT Acquisitions · 2026 Vet Specialty Hospital Signal
Why Vet Specialty Trades at 16x-18x EBITDA
Across our buy-side conversations with veterinary specialty acquirers in 2026:
- Cash-pay revenue mix above 70% is the platform threshold. Pet insurance penetration remains under 5% of US pets; cash-pay reality protects margins from payer pressure and drives the premium tier.
- Multi-specialty + 24-hour ER + advanced imaging is the platform-grade formula. Operators with surgery + IM + oncology + ophthalmology + ER + CT/MRI capacity command the 16x-18x EBITDA tier.
- Specialist roster retention drives the operating moat. Sub-5% annual board-certified specialist turnover post-close is the platform-thesis lynchpin; high turnover caps multi-turn premium.
Multiple at a Glance · 2026
Vet Specialty Hospital Sale Multiples · 2026
Highest multiples in healthcare services.
Source: CT Acquisitions analysis. Mars Veterinary Health (VCA / BluePearl), Thrive Pet Healthcare, NVA, MedVet, Ethos Veterinary Health + PE-backed veterinary specialty platforms.
Related Cluster GuideFor the general-vet sale companion on how to sell a veterinary practice, see our reference guide.
| Target | Buyer | Year | What it tells us |
|---|---|---|---|
| Mars Petcare continued integration | Mars Inc. (private) | 2017-2025 | Mars acquired VCA in 2017 for $7.7B; continues integration with BluePearl + Banfield. |
| NVA expansion | KKR + Berkshire Partners | 2022-2025 | Major PE-backed vet platform crossed 1,400+ hospitals globally. |
| Thrive Pet Healthcare growth | TSG Consumer Partners | 2022-2025 | PE-backed multi-state vet platform continues expansion to ~400+ hospitals. |
| MedVet specialty expansion | PE-backed | 2022-2025 | Specialty + ER vet platform continues regional rollups. |
| VEG (Veterinary Emergency Group) growth | PE-backed | 2022-2025 | ER-only multi-site platform continues aggressive expansion. |
| Ethos Veterinary Health continued integration | PE-backed | 2022-2025 | Multi-specialty vet platform continues consolidation post Compassion-First merger. |
The named buyer landscape
Mars Petcare Veterinary Health (the dominant US vet platform)
- VCA Animal Hospitals, ~1,000+ general practice + multi-specialty hospitals.
- BluePearl, ~115+ veterinary specialty + emergency hospitals.
- Banfield Pet Hospital, ~1,000+ clinics in PetSmart stores (general practice focus).
- All three operate under Mars Petcare Veterinary Health, the subsidiary of Mars Inc.
Major PE-backed national platforms
- National Veterinary Associates / NVA (KKR + Berkshire Partners), ~1,400+ hospitals globally.
- Thrive Pet Healthcare (TSG Consumer Partners), ~400+ hospitals.
- Ethos Veterinary Health (formerly Compassion-First Pet Hospitals), ~130+ hospitals.
- MedVet (PE-backed), specialty + ER focus, ~40+ specialty hospitals.
- Veterinary Emergency Group / VEG (PE-backed), ER-only multi-site, ~60+ ER hospitals.
- AmeriVet Veterinary Partners (PE-backed).
- Encore Vet Group (PE-backed).
PE sponsors active in this space
- KKR + Berkshire Partners (NVA), TSG Consumer Partners (Thrive Pet Healthcare), Carlyle Group, Apax Partners, JAB Holding Company, plus multiple consumer/healthcare PE funds.
What each buyer will pay for vs. what they reject
- Will pay premium for: multi-specialty referral capability (surgery, internal medicine, oncology, neurology, cardiology, ophthalmology, dermatology, dentistry), 24-hour ER coverage, cash-pay revenue model (~70%+ cash, minimal pet-insurance friction), board-certified specialist bench (DACVS surgery, DACVIM internal medicine, DACVO ophthalmology, etc.), strong referring DVM (rDVM) network, modern operating system (Cornerstone, ezyVet, Provet Cloud, IDEXX Neo, IDEXX MyVMA), real-estate optionality.
- Will compress or reject: general-practice-only without specialty mix, no 24-hour ER, owner-veterinarian dependence (single-DVM dependence), weak rDVM relationships, weak specialist bench, legacy operating system, weak emergency triage protocols.
The operator-level KPI playbook buyers will diligence
Specialty and case mix
- Specialty mix: Surgery, internal medicine, oncology, neurology, cardiology, ophthalmology, dermatology, dentistry, behavior, theriogenology.
- 24-hour ER coverage.
- Surgical case volume.
- Average revenue per case by specialty.
Revenue model
- Cash-pay percentage: 70%+ benchmark (no insurance complexity).
- Pet insurance percentage: Growing (~3-5% currently, projected higher).
- CareCredit / financing percentage.
- Wellness plan revenue.
Referring DVM (rDVM) network
- Active rDVM count.
- Referral volume by rDVM.
- rDVM concentration (no single rDVM above 5%).
- rDVM portal and communication infrastructure.
Provider bench
- Board-certified specialist count by specialty (DACVS, DACVIM, DACVO, DACVD, ACVECC, etc.).
- Emergency-trained veterinarian count.
- Veterinary technician count and certifications (RVT, LVT, CVT).
- Provider compensation model.
- Equity-rollover expectations (vet specialty deals typically 20-40% rollover).
Operating system
- Practice management software: Cornerstone (the operator standard), ezyVet, Provet Cloud, IDEXX Neo, IDEXX MyVMA, AVImark.
- Lab/imaging integration: IDEXX, Antech, Heska.
- Online client portal and digital communication.
Dangers and traps
1. General-practice-only without specialty mix
Compresses to general-vet multiples (4x-7x EBITDA) vs. specialty (10x-18x).
2. No 24-hour ER
24-hour ER coverage is the major multiple-builder for specialty hospitals.
3. Owner-veterinarian dependence
Single-DVM dependence compresses materially; build the specialist bench.
4. Weak rDVM network
Referring DVM relationships are the patient pipeline.
5. Weak specialist bench
Board-certified specialists are scarce and the multiple-driver.
6. Legacy operating system
Cornerstone, ezyVet, Provet Cloud, IDEXX are operator-standard.
7. Real-estate quality
Hospital infrastructure age and capex history matter.
8. Emergency triage protocols
Weak ER protocols compress; emergency revenue is high-margin.
Our POV in 2026
Veterinary specialty hospital M&A is one of the highest-multiple healthcare-services categories (10x-18x EBITDA) driven by cash-pay revenue model, aging-pet demand, and specialty premium. Mars Petcare Veterinary Health (VCA + Banfield + BluePearl) dominates. NVA (KKR + Berkshire Partners), Thrive Pet Healthcare (TSG Consumer Partners), Ethos, MedVet, and VEG compete. PE sponsors continue aggressive consolidation.
The right time to prepare is 12-18 months before going to market, build specialty mix, ensure 24-hour ER coverage, develop rDVM network, modernize operating system, build specialist bench.
Preparing your business for sale: 12-18 months out
- Get multi-year audited financials.
- Build specialty mix (surgery, internal medicine, oncology, neurology, cardiology).
- Ensure 24-hour ER coverage if not present.
- Develop rDVM network and referral infrastructure.
- Modernize operating system (Cornerstone, ezyVet, Provet Cloud, IDEXX).
- Build board-certified specialist bench.
- Document cash-pay and CareCredit revenue mix.
- Document add-backs.
- Run a competitive process. Mars Petcare Veterinary Health (VCA + BluePearl + Banfield), National Veterinary Associates / NVA (KKR + Berkshire Partners), Thrive Pet Healthcare (TSG Consumer Partners), Ethos Veterinary Health, MedVet, Veterinary Emergency Group / VEG, AmeriVet Veterinary Partners, Encore Vet Group, plus PE sponsors directly.
About the Author
Christoph Totter is the founder of CT Acquisitions, an M&A advisory firm working both sides of the table, headquartered in Sheridan, Wyoming. We work directly with 500+ buyers, search funders, family offices, lower middle-market PE, and strategic consolidators, including direct mandates with the largest home services consolidators that other intermediaries can’t access. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing. Connect on LinkedIn · Get in touch
Free, No Email Required
Get a personalized valuation in 90 seconds
Answer six quick questions and we’ll give you a sector-adjusted EBITDA multiple range plus the specific factors driving your number up or down.
The five pillars of how CT Acquisitions works
Sell side for owners, buy side for acquirers, plus exit planning.
No fee on buy-side introductions. Sell side paid on success.
Search funders, family offices, lower-middle-market PE, strategics.
Introductions to the right buyers only. No public listing.
Not 9-12 months. Not 18 months. Months, not years.
No Pitch · No Pressure
Ready to start a confidential conversation?
Tell us about your business. We’ll tell you what it’s likely worth, whether we have qualified buyers in our network, and what the next 60-120 days could look like. No engagement letter. No retainer. Walk at any time.
Frequently asked questions
What is the typical multiple for a veterinary specialty hospital in 2026?
Mixed practices with limited ER ($1-3M EBITDA) typically sell at 8x-11x EBITDA. Dedicated 24-hour ER hospitals ($2-5M EBITDA) go 10x-13x. Single-site multi-specialty referral hospitals ($3-8M EBITDA, surgery + internal medicine + emergency) go 12x-15x. Mid-size multi-site specialty platforms ($8-25M EBITDA) go 13x-16x. Premium scale platforms ($25M+ EBITDA, multi-state, comprehensive specialty + ER + boarding) reach 15x-18x+. These are among the highest multiples in healthcare-services M&A.
Who are the active buyers of veterinary specialty hospitals right now?
Mars Petcare Veterinary Health (Mars Inc. subsidiary, includes VCA Animal Hospitals ~1,000+ general/specialty, BluePearl ~115+ specialty, Banfield ~1,000+ PetSmart clinics, total ~2,100+ hospitals/clinics; the dominant US vet platform). PE-backed: National Veterinary Associates / NVA (KKR + Berkshire Partners, ~1,400+ hospitals globally), Thrive Pet Healthcare (TSG Consumer Partners, ~400+), Ethos Veterinary Health (~130+), MedVet (specialty + ER focus, ~40+ specialty hospitals), Veterinary Emergency Group / VEG (ER-only, ~60+), AmeriVet Veterinary Partners, Encore Vet Group. PE sponsors: KKR + Berkshire Partners, TSG Consumer Partners, Carlyle Group, Apax Partners, JAB Holding Company.
What hurts a veterinary specialty hospital’s valuation most?
General-practice-only without specialty mix (compresses to general-vet multiples), no 24-hour ER coverage (the major specialty multiple-builder), owner-veterinarian dependence with weak specialist bench, weak referring DVM (rDVM) network, legacy operating system, weak emergency triage protocols, single-state operations, and real-estate quality issues.
Why are veterinary specialty multiples so high?
Vet specialty hospitals have unusually attractive economics: cash-pay revenue model (~70%+ cash, minimal insurance complexity), aging-pet-population structural demand, scarce board-certified specialist bench creating supply constraint, 24-hour ER coverage with high-margin emergency cases, and durable referring DVM network relationships. The combination drives 10x-18x EBITDA multiples vs. 4x-7x for general veterinary practices.
Do I have to pay a broker fee?
No. CT Strategic Partners runs a M&A advisory model. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing.
How long does it take to sell a veterinary specialty hospital?
Typical process 5-9 months. Real-estate diligence extends timing. Add 12-18 months of preparation.
What is the typical equity rollover in a vet specialty MSO transaction?
Vet specialty deals typically include 20-40% equity rollover for selling veterinarians.
When should I start preparing if I plan to sell in 2027 or 2028?
12-18 months before going to market. Highest-leverage work: build specialty mix, ensure 24-hour ER coverage, develop rDVM network, modernize operating system, build board-certified specialist bench.
Related research
- How to sell a veterinary practice (general)
- How to sell a MedSpa
- How to sell a dermatology practice
- How to sell an ophthalmology practice
- How to sell an urgent care center
- How to sell an imaging center
- How to sell a clinical laboratory
- Healthcare business valuation
- Which industries is PE buying most in 2026
- Business broker alternative